Dexcom Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- Japan has no plans to overhaul pension funds' asset allocation, sources say
DexCom (DXCM) Tops Q2 EPS by 44c, Revenues Beat; Offers FY20 Revenue Outlook
July 28, 2020 4:06 PM EDTDexCom (NASDAQ: DXCM) reported Q2 EPS of $0.79, $0.44 better than the analyst estimate of $0.35. Revenue for the quarter came in at $451.8 million versus the consensus estimate of $415.74 million.
Second Quarter 2020 Financial Highlights:
Revenue grew 34% versus the same quarter of the prior year to $451.8 millionU.S. revenue growth of 38% and international revenue growth of 21%GAAP operating income of $67.8 million or 15.0% of revenue, an increase of 1520 basis points... More